��������

Dr. Joerg Neermann is a Member of the Board of Directors at Immunic Therapeutics. Dr. has over 20 years of experience in the pharmaceutical and biotech industries.

Dr. Neermann was previously a Board Member at Imcyse SA from January 2019 to December 2021. Dr. also served as a Board Member at Immunic Therapeutics, Immunic AG, ViCentra, Kuros Biosciences, EyeSense AG, and Curetis AG. In addition, they were a Partner at LSP from January 2007 to April 2021.

Dr. Neermann received their M.D. from the University of Cologne and their Ph.D. in Molecular Biology from the Max Planck Institute for Biochemistry.

Dr. Joerg Neermann received their Ph.D. in Biotechnology from Technische Universität Braunschweig. Dr. also holds a degree in Biotechnology from the Massachusetts Institute of Technology.